SCHEMBL8274944

SCHEMBL8274944

C[C@@H]1CCCN1C(=O)[C@H](O)[C@@H](O)C(=O)NCC1CCN(c2ccc(F)cc2N)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 13/20 0.47
▸ KDM4E B2RXH2 3/20 0.42
▸ HTT P42858 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ ADAM10 O14672 1/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ MMP14 P50281 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ NR4A1 P22736 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273310 0.86 GAA (0.44) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273591 0.86 ADAM17 (0.43) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273592 0.85 HTT (0.46) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8275186 0.83 ADAM17 (0.70) ADAM17ADAM10MMP2MMP3MMP13
SCHEMBL8273579 0.82 CTSS (0.41) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273588 0.82 ADAM17 (0.40) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8273578 0.81 ADAM17 (0.39) ADAM17KDM4EHTTALDH1A1GAA
SCHEMBL8274407 0.81 ADAM17 (0.43) ADAM17HTTALDH1A1GAAL3MBTL1
SCHEMBL8276118 0.81 ADAM17 (0.43) ADAM17HTTALDH1A1GAAL3MBTL1
SCHEMBL8273311 0.81 ADAM17 (0.41) ADAM17KDM4EHTTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback